Promoter Pradeep Kumar Chunilal Khetani increased his shareholding in Ambar Protein Industries Limited to 12.35% through the acquisition of 22,378 equity shares on June 9, 2026. The transaction, executed via open market purchases, represents 0.39% of the company's total paid-up capital and was disclosed to BSE Limited under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Prior to the acquisition, Khetani held 687,755 equity shares, accounting for 11.96% of the total voting capital. The purchase of 22,378 shares raised his total holding to 710,133 equity shares. The company's equity share capital remains INR 5,75,00,000, consisting of 57,50,000 equity shares of INR 10 each.

Shareholding Details

The following table outlines the changes in the promoter's shareholding:

The acquisition was conducted solely through the open market. The total diluted share and voting capital of the target company remains unchanged at INR 5,75,00,000. The disclosure confirms that the acquirer belongs to the promoter group of Ambar Protein Industries Limited.

Market Decipher has released the Global Protein Market Report, 2026–2036, detailing a global protein industry valued at $133 billion that is undergoing a structural reset. The report identifies three converging forces reshaping the market: a pharmaceutical revolution driven by GLP-1 medications, a once-in-a-generation whey supply crisis with spot prices at USD 11/lb, and a fundamental shift in consumer expectations for protein functionality. These disruptions are creating a volatile environment where the headline 8.4% CAGR understates the immediate volatility in pricing and supply chains.

Market Segmentation and Growth

The report breaks down the market into four primary segments: Protein Supplements, High-Protein FMCG, Protein Ingredients, and Emerging Proteins. Protein Supplements are valued at USD 33.5 Bn with a ~13.2% CAGR, while High-Protein FMCG represents the largest segment at USD 70.2 Bn with an ~8.1% CAGR. Protein Ingredients are valued at USD 30.1 Bn with an ~11.6% CAGR. Emerging Proteins, including precision fermentation and insect protein, are projected to grow at a 17% CAGR from a smaller base of USD 15.2 Bn.

Protein Supplements Market Breakdown

Whey Supply Crisis and Capacity Constraints

The report highlights a critical whey supply crisis driven by a structural demand shock and insufficient processing infrastructure. WPC80 costs have surged 108% over two years, while WPI is up 139%. US WPC and WPI volumes are largely forward-contracted into 2026, forcing global buyers to shift sourcing to Europe and regional alternatives. The global dairy industry has announced approximately USD 11 billion in investments, but significant supply relief is not expected until Q3 2027 or later. Major capacity additions include Glanbia adding 10 million pounds of WPI capacity and Tirlán committing €126 million to premium whey expansion.

High-Protein FMCG Expansion

High-protein products are moving beyond specialist stores into mainstream grocery aisles, appearing in items such as Pop-Tarts, Kraft Mac & Cheese, and Doritos. This transformation is driving the High-Protein FMCG segment, which includes categories like RTD protein drinks, protein bars, and high-protein yogurt. The segment is projected to grow from USD 70.2 Bn to USD 153.6 Bn by 2036. Key growth areas include clear/juice-style RTD protein beverages and GLP-1-specific nutritional products, such as Danone's Oikos protein shake launched in May 2025.

High Protein FMCG Market Breakdown

Protein Ingredients and Emerging Technologies

The Protein Ingredients market is projected to grow from USD 30.1 Bn to USD 93 Bn by 2036. The report identifies Pea Protein Isolate (12.5% CAGR), Collagen Peptides (11.4% CAGR), and WPI Bulk (14.0% CAGR) as high-conviction investment theses. Emerging technologies, particularly precision fermentation, are moving from speculation to commercial reality, with the segment projected to reach USD 22,387 million by 2036 at a 48% CAGR. Regulatory approvals from bodies like the FDA, EFSA, and FSSAI remain critical gating factors for these emerging segments.

Protein Ingredients Market Breakdown

GLP-1 and Strategic Outlook

The adoption of GLP-1 medications is tightening whey demand as protein is prescribed to preserve lean mass. The GLP-1 diet protein market is valued at USD 3.1 Bn in 2026 and is projected to reach USD 15.4 Bn by 2036, growing at a 17.4% CAGR. The report warns that companies waiting for the supply crisis to resolve risk losing competitive advantage, as early commitments to capacity from processors like Glanbia, Tirlán, and Fonterra are pre-allocating available WPI output.